LeMaitre to Participate at Upcoming Investor Conferences in March
LeMaitre Vascular (Nasdaq:LMAT) said management will participate in five investor conferences in March 2026, including presentations and 1x1 meetings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LeMaitre Vascular (Nasdaq:LMAT) said management will participate in five investor conferences in March 2026, including presentations and 1x1 meetings.
Events:
- Leerink Partners Global Healthcare Conference — Mar 10, 2026, W South Beach, Miami, presentation 1:00 PM EDT
- Citizens Life Sciences Conference — Mar 11, 2026, Eden Roc Miami Beach, presentation 1:40 PM EDT
- Barclays Annual Global Healthcare Conference — Mar 12, 2026, available for 1x1 meetings
- KeyBanc Capital Markets Healthcare Forum — Mar 17, 2026, virtual, presentation 3:45 PM EDT
- 38th Annual ROTH Conference — Mar 22-24, 2026, available for 1x1 meetings and possible presentation
Details
News Market Reaction – LMAT
On Feb 27, the day this news came out, LMAT closed 4.85% below the previous close.
Data tracked by StockTitan Argus for the Feb 27 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in five upcoming investor conferences in March.
Leerink Partners Global Healthcare Conference
Tuesday, March 10, 2026
W South Beach, Miami
Management will present at 1:00 PM EDT
Citizens Life Sciences Conference
Wednesday, March 11, 2026
Eden Roc Miami Beach, Miami
Management will present at 1:40 PM EDT
Barclays Annual Global Healthcare Conference
Thursday, March 12, 2026
Management will be available for 1x1 meetings
KeyBanc Capital Markets Healthcare Forum
Tuesday, March 17, 2026
Virtual
Management will present at 3:45 PM EDT
38th Annual ROTH Conference
March 22-24, 2026
Management will be available for 1x1 meetings and may also participate in a presentation or fireside chat.
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
LeMaitre is a registered trademark of LeMaitre Vascular, Inc.

Contact: Greg Manker Director Business Development & Investor Relations LeMaitre Vascular, Inc. Phone: (781) 362-1260 Email: gmanker@lemaitre.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.